Biomea Fusion, Inc. Common Stock (BMEA) News

Latest headlines that mention BMEA, newest first · each headline opens the original publisher

BMEA quote

Last price: $0.64
Day change: +5.92%
Next earnings: 2026-11-03

Quote & chart Expected move Insider trading IV rank history

BMEA headlines

latest coverage

Seeking Alpha News 13d ago

Biomea Fusion, Inc. (BMEA) Discusses BMF-650 Phase I Topline Results and Potential for Separating GI Side Effects from Weight Loss - Slideshow

General T2BMEA

Seeking Alpha News 13d ago

Biomea Fusion, Inc. (BMEA) Discusses BMF-650 Phase I Topline Results and Potential for Separating GI Side Effects from Weight Loss Transcript

General T2BMEA

Investing.com 14d ago

Biomea Fusion to report Phase I trial results Tuesday

General T3BMEA

Seeking Alpha 1mo ago

Biomea Fusion announces proposed public offering of shares

General T2BMEA

Seeking Alpha News 1mo ago

Biomea Fusion, Inc. (BMEA) Presents at H.C. Wainwright 28th Annual Global Investment Conference - Slideshow

General T2BMEA

Investing.com 2mo ago

Biomea Fusion stock surges on diabetes trial enrollment completion

General T3BMEA

Investing.com 2mo ago

H.C. Wainwright reiterates Biomea Fusion stock rating on trial enrollment

General T3BMEA

Investing.com 2mo ago

Why is Biomea Fusion stock climbing today?

General T3BMEA

Seeking Alpha 2mo ago

Biomea Fusion GAAP EPS of -$0.12 beats by $0.10

Earnings T2BMEA

Seeking Alpha News 4mo ago

Biomea Fusion, Inc. (BMEA) Presents at American Diabetes Association (ADA) 86th Scientific Sessions - Slideshow

General T2BMEA

Seeking Alpha 5mo ago

Biomea Fusion GAAP EPS of -$0.17 beats by $0.07

Earnings T2BMEA

Seeking Alpha News 5mo ago

Biomea Fusion, Inc. (BMEA) Discusses Developments in Diabetes With Emphasis on Icovamenib and Clinical Trial Insights Transcript

General T2BMEA

BMEA news alerts

Get an alert by email or push when a new headline mentions BMEA.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.